Pediatrix Medical Group, Inc. (NYSE:MD) Short Interest Down 22.8% in December

Pediatrix Medical Group, Inc. (NYSE:MD) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 2,300,000 shares, a decline of 22.8% from the November 30th total of 2,980,000 shares. Approximately 2.7% of the company’s stock are short sold. Based on an average daily trading volume, of 758,400 shares, the short-interest ratio is presently 3.0 days.

Analyst Ratings Changes

A number of brokerages recently weighed in on MD. Macquarie began coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective for the company. Mizuho increased their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. StockNews.com lowered Pediatrix Medical Group from a “buy” rating to a “hold” rating in a research report on Thursday, December 19th. Jefferies Financial Group increased their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Finally, Truist Financial boosted their price target on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a report on Monday, November 4th. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and an average target price of $16.42.

Pediatrix Medical Group Stock Performance

MD opened at $13.49 on Friday. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $16.41. The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of -4.41, a price-to-earnings-growth ratio of 2.00 and a beta of 1.57. The business has a 50 day moving average price of $14.29 and a two-hundred day moving average price of $11.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. Pediatrix Medical Group’s revenue was up .9% on a year-over-year basis. During the same period in the prior year, the company earned $0.29 EPS. Research analysts predict that Pediatrix Medical Group will post 1.26 EPS for the current fiscal year.

Insider Buying and Selling

In other Pediatrix Medical Group news, EVP Mary Ann E. Moore sold 8,108 shares of Pediatrix Medical Group stock in a transaction on Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the transaction, the executive vice president now owns 135,810 shares of the company’s stock, valued at $2,172,960. The trade was a 5.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Mark S. Ordan sold 27,600 shares of the business’s stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total transaction of $423,660.00. Following the sale, the director now owns 138,683 shares of the company’s stock, valued at approximately $2,128,784.05. The trade was a 16.60 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Quest Partners LLC increased its position in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares in the last quarter. nVerses Capital LLC purchased a new position in Pediatrix Medical Group during the 2nd quarter worth approximately $31,000. Innealta Capital LLC acquired a new stake in Pediatrix Medical Group during the 2nd quarter valued at $33,000. Quarry LP lifted its holdings in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares in the last quarter. Finally, CWM LLC boosted its position in shares of Pediatrix Medical Group by 134.0% in the third quarter. CWM LLC now owns 6,427 shares of the company’s stock worth $74,000 after buying an additional 3,681 shares during the period. Institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.